Skip to content
10-Q

Quarterly Report

KEDEM PHARMACEUTICALS INC.

0001493152-13-000006

← back to feed
Filed
Jan 2, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Dec 31, 2012 25.39M sh
Operating Cash Flow Q2 2013 · Nov 30, 2012 −$205.2K
Operating Cash Flow Q2 2013 · Nov 30, 2012 −$353.48K
Operating Cash Flow Q2 2013 · Nov 30, 2012 −$4.92M
Cash And Equivalents Q2 2013 · Nov 30, 2012 $54.17K
Cash And Equivalents Q2 2013 · Aug 31, 2012 $236.78K
Cash And Equivalents Q2 2013 · May 31, 2012 $294.94K
Stockholders Equity Q2 2013 · Nov 30, 2012 −$4.74M
Stockholders Equity Q2 2013 · May 31, 2012 −$3.28M
Current Liabilities Q2 2013 · Nov 30, 2012 $5.1M
Current Liabilities Q2 2013 · May 31, 2012 $4.4M
Current Assets Q2 2013 · Nov 30, 2012 $95.85K
Current Assets Q2 2013 · May 31, 2012 $416.67K
Total Assets Q2 2013 · Nov 30, 2012 $358.85K
Total Assets Q2 2013 · May 31, 2012 $1.12M
Sga Expense Q2 2013 · Nov 30, 2012 $9.66K
Sga Expense Q2 2013 · Nov 30, 2012 $62.41K
Sga Expense Q2 2013 · Nov 30, 2012 $1.02M
Rd Expense Q2 2013 · Nov 30, 2012 $103.17K
Rd Expense Q2 2013 · Nov 30, 2012 $220.1K
Rd Expense Q2 2013 · Nov 30, 2012 $2.25M
Net Income Q2 2013 · Nov 30, 2012 −$679.17K
Net Income Q2 2013 · Nov 30, 2012 −$1.43M
Net Income Q2 2013 · Nov 30, 2012 −$13.8M
Net Income Q2 2013 · May 31, 2012 −$5.91M
Operating Income Q2 2013 · Nov 30, 2012 −$370.16K
Operating Income Q2 2013 · Nov 30, 2012 −$783.81K
Operating Income Q2 2013 · Nov 30, 2012 −$7.29M